Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) has announced its participation in the 2024 Wells Fargo Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, September 4, 2024, at 8:00 a.m. Eastern Time. Investors and interested parties can access a live webcast of Kiniksa's presentation through the Investors & Media section of the company's official website at www.kiniksa.com. For those unable to attend the live event, a replay will be made available on Kiniksa's website within approximately 48 hours after the presentation concludes.
Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) ha annunciato la sua partecipazione alla Conferenza Sanitaria Wells Fargo 2024. La direzione dell'azienda parteciperà a una discussione informale mercoledì 4 settembre 2024, alle 8:00 a.m. East Time. Gli investitori e le parti interessate possono accedere a una webcast dal vivo della presentazione di Kiniksa attraverso la sezione Investitori & Media sul sito ufficiale dell'azienda all'indirizzo www.kiniksa.com. Per coloro che non possono partecipare all'evento dal vivo, una registrazione sarà resa disponibile sul sito di Kiniksa all'incirca 48 ore dopo la conclusione della presentazione.
Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) ha anunciado su participación en la Conferencia de Salud Wells Fargo 2024. La gestión de la empresa participará en una charla informal el miércoles 4 de septiembre de 2024, a las 8:00 a.m. hora del Este. Los inversores y partes interesadas pueden acceder a una transmisión en vivo de la presentación de Kiniksa a través de la sección de Inversores y Medios en el sitio web oficial de la empresa en www.kiniksa.com. Para aquellos que no puedan asistir al evento en vivo, se hará disponible una repetición en el sitio web de Kiniksa aproximadamente 48 horas después de que concluye la presentación.
Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA)는 2024 웰스 파고 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 회사 경영진은 가벼운 대화를 진행할 예정이며, 이는 2024년 9월 4일 수요일 오전 8시 동부 표준시에 이루어집니다. 투자자와 관심 있는 분들은 Kiniksa의 프레젠테이션을 회사 공식 웹사이트의 투자자 및 미디어 섹션에서 실시간 웹 캐스트로 시청할 수 있습니다. 라이브 이벤트에 참석하지 못하는 분들을 위해 프레젠테이션 종료 후 약 48시간 이내에 Kiniksa 웹사이트에서 재방송이 제공될 예정입니다.
Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) a annoncé sa participation à la Conférence sur la Santé Wells Fargo 2024. La direction de la société participera à une discussion informelle le mercredi 4 septembre 2024, à 8h00 heure de l'Est. Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation de Kiniksa via la section Investisseurs & Médias du site officiel de l'entreprise à l'adresse www.kiniksa.com. Pour ceux qui ne peuvent pas assister à l'événement en direct, un rediffusion sera mise à disposition sur le site de Kiniksa dans environ 48 heures après la conclusion de la présentation.
Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) hat seine Teilnahme an der Wells Fargo Healthcare Conference 2024 angekündigt. Das Management des Unternehmens wird am Mittwoch, den 4. September 2024, um 8:00 Uhr Eastern Time an einem Feuerstuhlgespräch teilnehmen. Investoren und Interessierte können über den Bereich Investoren & Medien der offiziellen Website des Unternehmens unter www.kiniksa.com auf einen Live-Webcast der Präsentation von Kiniksa zugreifen. Für diejenigen, die nicht an der Live-Veranstaltung teilnehmen können, wird eine Wiederholung etwa 48 Stunden nach Abschluss der Präsentation auf der Website von Kiniksa verfügbar gemacht.
- None.
- None.
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 at 8:00 a.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets, ARCALYST®, abiprubart, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
ARCALYST® is a registered trademark of Regeneron Pharmaceuticals, Inc.
Every Second Counts! ®
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
FAQ
When is Kiniksa Pharmaceuticals (KNSA) presenting at the 2024 Wells Fargo Healthcare Conference?
How can I watch Kiniksa Pharmaceuticals' (KNSA) presentation at the Wells Fargo Healthcare Conference?
Will there be a replay available of Kiniksa Pharmaceuticals' (KNSA) presentation at the 2024 Wells Fargo Healthcare Conference?
What type of presentation will Kiniksa Pharmaceuticals (KNSA) give at the 2024 Wells Fargo Healthcare Conference?
